An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase - PubMed (original) (raw)

An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase

Andrew Mehle et al. Cell Host Microbe. 2008.

Abstract

Transmission of avian influenza virus into human populations has the potential to cause pandemic outbreaks. A major determinant of species tropism is the identity of amino acid 627 in the PB2 subunit of the heterotrimeric influenza polymerase; glutamic acid predominates in avian PB2, whereas lysine occupies this position in human isolates. We show that a dominant inhibitory activity in human cells potently and selectively restricts the function of polymerases containing an avian-like PB2 with glutamic acid at residue 627. Restricted polymerases fail to assemble into ribonucleoprotein complexes, resulting in decreased genome transcription, replication, and virus production without any significant effect on relative viral infectivity. Understanding the molecular basis of this species-specific restriction should provide strategies to prevent and treat avian influenza outbreaks in humans.

PubMed Disclaimer

Figures

Figure 1

Figure 1. PB2 amino acid 627 decreases virus production by regulating polymerase activity in human cells

(A) Recombinant A/WSN/33 virus was produced in 293T cells expressing WT or K627E PB2. Viral titers (plaque forming units (pfu)/ml) were measured by plaque assays on MDCK cells (n=2–3+/− standard deviation) before and after normalizing inoculums based on hemaggluttination units. (B) Viral polymerase activity was determined in primate cells transfected with expression plasmids for PB1, PA, NP, the indicated PB2-TAP, and a vRNA-luciferase reporter plasmid. Control cells were transfected with reporter plasmid alone. Luciferase activity was determined in cell extracts. PB2-TAP and NP-V5 were detected by western blot. Molecular weights are shown in kilodaltons. (C) Polymerase activity assays were performed in the avian cells as in (B), except the vRNA-luciferase reporter was driven by a chicken pol I promoter. For all activity assays, n=3 +/− standard deviation.

Figure 2

Figure 2. A dominant inhibitory activity restricts PB2 function in human cells

(A) Experimental strategy for formation of heterokaryons by expression of the fusogenic VSV-G protein. Heterokaryon formation between 293T cells expressing GFP and DF1 cells expressing RFP was monitored by the detection of dual-fluorescent cells (arrowheads). (B) Polymerase activity in heterokaryons expressing NP, PB1, PA, and no PB2, WT, or K627E PB2-TAP was determined by luciferase assay. Protein expression was monitored by western blot. n=3 +/− standard deviation.

Figure 3

Figure 3. Avian-like PB2 mutants form trimeric polymerase complexes in the nucleus

(A) Influenza polymerase was TAP-tag purified from nuclear extracts of 293T cells expressing PB1, PA, and PB2-TAP. Proteins were detected by Coomassie staining. (B) Subcellular localization of PB1 and PB2 were determined by western blotting of nuclear (N) and cytoplasmic (C) extracts prepared from 293T cells transfected with expression vectors for PB1-TAP, PA, and the indicated PB2-TAP. The identity of each fraction was confirmed by western blotting for tubulin, a cytoplasmic protein, and TATA-binding protein (TBP), a nuclear protein. Molecular weight in kilodaltons is shown.

Figure 4

Figure 4. PB2 K627E mutation prevents assembly of vRNP without disrupting the NP binding site

Cell lysates prepared from 293T (A) or DF1 (B) cells transfected with expression vectors for PB1, PA, NP, WT or K627E PB2-HA, and the vRNA-luciferase reporter were subject to immunoprecipitation and western blotting. Where indicated, lysates were treated with RNase. (C) and (D) Immunoprecipitations and western blots were performed on lysates from 293T (C) and DF1 (D) cells expressing NP and WT or K627E PB2. The levels and ratio of PB2 and NP were the same as in (A) and (B). (E) Primer extension assays were used to detect RNAs produced in 293T cells or DF1 cells expressing viral polymerases containing WT or mutant PB2 in the presence of a vRNA-reporter. Products are indicated and the size of a DNA standard is shown in nucleotides. A non-specific band (*) serves as an internal loading control.

Figure 5

Figure 5. Defective assembly of mutant polymerase into vRNP is overcome during late stages of infection

(A) Recombinant virus was produced in 293T cells transfected with pTM-pol I-WSN-All and expression vectors for NP, PB1, PA, PB2, and WT or K627E PB2-TAP. PB2 and PB2-TAP were detected by western blot of cell lysate or cell-free virions with anti-PB2 serum. (B) PB2-TAP was precipitated with rabbit IgG-agarose from virus-producing cell lysates. Co-precipitating NP was detected by anti-NP western blot. (C) Purified virus was lysed and separated on a linear 30–60% glycerol gradient. Where indicated, 1 % deoxycholate (DOC) was present during viral lysis. Fractions were collected and PB2 and NP were detected by western blot. Non-specific bands at the top of the gradient are indicated (*).

References

    1. Almond JW. A single gene determines the host range of influenza virus. Nature. 1977;270:617–618. - PubMed
    1. Area E, Martin-Benito J, Gastaminza P, Torreira E, Valpuesta JM, Carrascosa JL, Ortin J. 3D structure of the influenza virus polymerase complex: localization of subunit domains. Proc Natl Acad Sci U S A. 2004;101:308–313. - PMC - PubMed
    1. Biswas SK, Boutz PL, Nayak DP. Influenza virus nucleoprotein interacts with influenza virus polymerase proteins. J Virol. 1998;72:5493–5501. - PMC - PubMed
    1. Chen GW, Chang SC, Mok CK, Lo YL, Kung YN, Huang JH, Shih YH, Wang JY, Chiang C, Chen CJ, et al. Genomic signatures of human versus avian influenza A viruses. Emerg Infect Dis. 2006a;12:1353–1360. - PMC - PubMed
    1. Chen H, Li Y, Li Z, Shi J, Shinya K, Deng G, Qi Q, Tian G, Fan S, Zhao H, et al. Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J Virol. 2006b;80:5976–5983. - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources